vs

Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

Armour Residential REIT, Inc. is the larger business by last-quarter revenue ($50.4M vs $38.9M, roughly 1.3× CODEXIS, INC.). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs 24.7%, a 395.6% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs 81.3%). Over the past eight quarters, Armour Residential REIT, Inc.'s revenue compounded faster (108.0% CAGR vs 51.0%).

Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

ARR vs CDXS — Head-to-Head

Bigger by revenue
ARR
ARR
1.3× larger
ARR
$50.4M
$38.9M
CDXS
Growing faster (revenue YoY)
ARR
ARR
+216.5% gap
ARR
297.9%
81.3%
CDXS
Higher net margin
ARR
ARR
395.6% more per $
ARR
420.2%
24.7%
CDXS
Faster 2-yr revenue CAGR
ARR
ARR
Annualised
ARR
108.0%
51.0%
CDXS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARR
ARR
CDXS
CDXS
Revenue
$50.4M
$38.9M
Net Profit
$211.7M
$9.6M
Gross Margin
94.8%
Operating Margin
27.1%
Net Margin
420.2%
24.7%
Revenue YoY
297.9%
81.3%
Net Profit YoY
555.9%
192.5%
EPS (diluted)
$2.43
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARR
ARR
CDXS
CDXS
Q4 25
$50.4M
$38.9M
Q3 25
$38.5M
$8.6M
Q2 25
$33.1M
$15.3M
Q1 25
$36.3M
$7.5M
Q4 24
$12.7M
$21.5M
Q3 24
$12.8M
Q2 24
$7.0M
$8.0M
Q1 24
$17.1M
Net Profit
ARR
ARR
CDXS
CDXS
Q4 25
$211.7M
$9.6M
Q3 25
$159.3M
$-19.6M
Q2 25
$-75.6M
$-13.3M
Q1 25
$27.3M
$-20.7M
Q4 24
$-46.4M
$-10.4M
Q3 24
$-20.6M
Q2 24
$-48.4M
$-22.8M
Q1 24
$-11.5M
Gross Margin
ARR
ARR
CDXS
CDXS
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
ARR
ARR
CDXS
CDXS
Q4 25
27.1%
Q3 25
-220.3%
Q2 25
-83.9%
Q1 25
-271.6%
Q4 24
-34.2%
Q3 24
-129.0%
Q2 24
-284.9%
Q1 24
-69.6%
Net Margin
ARR
ARR
CDXS
CDXS
Q4 25
420.2%
24.7%
Q3 25
413.5%
-228.1%
Q2 25
-228.4%
-86.6%
Q1 25
75.2%
-274.3%
Q4 24
-366.8%
-48.4%
Q3 24
-160.8%
Q2 24
-693.8%
-285.2%
Q1 24
-67.4%
EPS (diluted)
ARR
ARR
CDXS
CDXS
Q4 25
$2.43
$0.13
Q3 25
$1.49
$-0.22
Q2 25
$-0.94
$-0.16
Q1 25
$0.32
$-0.25
Q4 24
$-0.91
$-0.12
Q3 24
$-0.29
Q2 24
$-1.05
$-0.32
Q1 24
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARR
ARR
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$63.3M
$78.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$2.3B
$50.5M
Total Assets
$21.0B
$147.8M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARR
ARR
CDXS
CDXS
Q4 25
$63.3M
$78.2M
Q3 25
$44.2M
$58.7M
Q2 25
$141.2M
$66.3M
Q1 25
$49.1M
$59.8M
Q4 24
$68.0M
$73.5M
Q3 24
$90.3M
Q2 24
$126.6M
$73.2M
Q1 24
$85.5M
Total Debt
ARR
ARR
CDXS
CDXS
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
ARR
ARR
CDXS
CDXS
Q4 25
$2.3B
$50.5M
Q3 25
$2.1B
$38.5M
Q2 25
$1.7B
$55.6M
Q1 25
$1.7B
$49.6M
Q4 24
$1.4B
$66.9M
Q3 24
$73.4M
Q2 24
$1.2B
$61.4M
Q1 24
$79.3M
Total Assets
ARR
ARR
CDXS
CDXS
Q4 25
$21.0B
$147.8M
Q3 25
$19.4B
$124.0M
Q2 25
$16.2B
$138.2M
Q1 25
$15.5B
$128.9M
Q4 24
$13.5B
$149.0M
Q3 24
$148.2M
Q2 24
$10.1B
$132.0M
Q1 24
$149.6M
Debt / Equity
ARR
ARR
CDXS
CDXS
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARR
ARR
CDXS
CDXS
Operating Cash FlowLast quarter
$124.2M
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
0.59×
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARR
ARR
CDXS
CDXS
Q4 25
$124.2M
$20.1M
Q3 25
$-37.8M
$-7.7M
Q2 25
$25.0M
$-18.0M
Q1 25
$101.5M
$-13.8M
Q4 24
$261.5M
$-16.5M
Q3 24
$-13.0M
Q2 24
$27.1M
$-12.2M
Q1 24
$-7.8M
Free Cash Flow
ARR
ARR
CDXS
CDXS
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
Q3 24
$-14.0M
Q2 24
$-12.6M
Q1 24
$-8.9M
FCF Margin
ARR
ARR
CDXS
CDXS
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
Q3 24
-109.0%
Q2 24
-157.5%
Q1 24
-52.2%
Capex Intensity
ARR
ARR
CDXS
CDXS
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
Q3 24
7.8%
Q2 24
5.0%
Q1 24
6.6%
Cash Conversion
ARR
ARR
CDXS
CDXS
Q4 25
0.59×
2.09×
Q3 25
-0.24×
Q2 25
Q1 25
3.71×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons